Evidence map›Paper›PMID 34326205›Full record

ArticleRMD open2021

Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis.

Valentin Ritschl, Ricardo J O Ferreira, Eduardo José Ferreira Santos, Rúben Fernandes, Essi Juutila, Erika Mosor, Paulo Santos-Costa, Kim Fligelstone, Linda Schraven, Georg Stummvoll and 5 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in RMD open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 7 countries.

Valentin RitschlSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-8763-8215
Ricardo J O FerreiraRheumatology, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.ORCID 0000-0002-2517-0247
Eduardo José Ferreira SantosRheumatology, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.ORCID 0000-0003-0557-2377
Rúben FernandesRheumatology, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.
Essi JuutilaMetropolia University of Applied Sciences, Helsinki, Finland.
Erika MosorSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-4293-0647
Paulo Santos-CostaHealth Sciences Research Unit: Nursing (UICISA: E), Nursing School of Coimbra (ESEnfC), Coimbra, Portugal.ORCID 0000-0003-0761-6548
Kim FligelstoneFederation of European Scleroderma Associations, London, UK.
Linda SchravenFederation of European Scleroderma Associations, Amsterdam, The Netherlands.
Georg StummvollKlinikum Malcherhof Baden, Baden, Austria.
Maria SalvadorRheumatology, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.
Janet L PooleOccupational Therapy Graduate Program, University of New Mexico, Albuquerque, New Mexico, USA.ORCID 0000-0003-3093-5707
Cornelia van den EndeDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.ORCID 0000-0002-4352-2824
Carina BoströmDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2506-687X
Tanja A StammSection for Outcomes Research, Medical University of Vienna, Vienna, Austria tanja.stamm@meduniwien.ac.at.ORCID 0000-0003-3073-7284
Hospitais da Universidade de Coimbra · PTLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · ATEscola Superior de Enfermagem de Coimbra · PTEuropean Hematology Association · NLHelsinki Metropolia University of Applied Sciences · FIKarolinska Institutet · SEMedical University of Vienna · ATSint Maartenskliniek · NLTuberous Sclerosis Association · GBUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNon-pharmacological interventions support patients with connective tissue diseases to better cope with and self-manage their diseases. This study aimed to map existing evidence on non-pharmacological interventions in patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and mixed connective tissue diseases regarding content, feasibility and potential suitability in an e-health setting.

methodsA literature search was performed in eight different databases in July 2020. The intervention's content was extracted using the 'Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide'. A Sankey diagram and descriptive statistics were used to analyse the data and illustrate the relationships between the interventions.

resultsOf 8198 identified records, 119 papers were eligible. One hundred and four of them (87.4%) were conducted between 2000 and 2020, mainly in the USA (SLE n=24 (21.2%), SSc n=16 (14.2%)), Brazil (SLE n=8 (7.1%), SSc n=5 (4.4%)) and Italy (SLE n=0 (0%), SSc n=12 (10.6%)). Fifty-two studies (SLE n=24 (21.2%), SSc n=28 (24.8%)) used multicomponent interventions. The single interventions were physical exercises (SLE n=16 (14.2%), SSc n=17 (15.0%)), coaching/counselling (SLE n=11 (18.0%), SSc n=0 (0%)) and education (SLE n=2 (1.8%), SSc n=3 (2.7%)). Primary outcomes focused on physical function (SLE n=1 (0.9%), SSc n=15 (13.3%)), mouth opening in SSc (n=4 (5.9%)) and physical capacity (SLE n=2 (1.8%), SSc n=1 (0.9%)). No interventions for mixed connective tissue disease were found.

conclusionThere was a great variety in the intervention's content due to differences in body structure, activity limitations and participation restrictions in SLE and SSc. These results highlight the need for personalised, multicomponent, non-pharmacological interventions, which could be delivered as e-health interventions.

Indexed as

Connective Tissue DiseasesLupus Erythematosus, SystemicScleroderma, SystemicTelemedicineHumanslupus erythematosusnursingoccupational therapyphysical therapy modalitiessclerodermasystemic

Identifiers

PMID34326205
PMCPMC8323400
OpenAlexW3185126705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.